OUR INVESTMENT IN BIOPIX-T – THE STARTUP COMPANY BEHIND IRIS – THE NOVEL PORTABLE MOLECULAR DIAGNOSTIC DEVICE FOR POINT OF CARE
- Posted by Metavallon VC Team
- On September 9, 2020
- No tags found
We are delighted to announce our latest Seed investment into biotech company BIOPIX-T, the startup company behind IRIS – the novel portable molecular diagnostic device for Point-of-Care. The investment round is joined by strategic angel investors from the healthcare and diagnostics sector. Founded in 2019 by George Papadakis, Electra Gizeli, Alexandros Pantazis, Nikolaos Fikas and […]
Read More



